EGFR and breast carcinoma: In previous studies [3–9], we tested different peptides to direct nanoparticles to different vascular biomarkers that represent various microenvironments of breast cancer, including αvβ3 integrin, P-selectin, EGFR, PTPμ, and fibronectin.